Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Loza

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Revista Espanola De Cirugia Ortopedica Y Traumatologia|July 11, 2017
GEDOS-SECOT consensus on the care process of patients with knee osteoarthritis and arthoplastyM A Ruiz Iban, A Tejedor, E Gil Garay, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 14, 2018
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015)R Cantón, E Loza, J Aznar, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 15, 2019
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)R Cantón, E Loza, J Aznar, et al.
The Journal of Infection|February 29, 2012
Emerging trends in candidemia: a higher incidence but a similar outcomeJ Fortún, P Martín-Dávila, E Gómez-García de la Pedrosa, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 1, 2021
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018)R Cantón, E Loza, R M Arcay, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Annals of the Rheumatic Diseases|November 27, 2008
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeK Visser, W Katchamart, E Loza, et al.
Lupus|December 18, 2014
Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosusJ M Pego-Reigosa, Í Rúa-Figueroa, F J López-Longo, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Revista Espanola De Cirugia Ortopedica Y Traumatologia|July 11, 2017
GEDOS-SECOT consensus on the care process of patients with knee osteoarthritis and arthoplastyM A Ruiz Iban, A Tejedor, E Gil Garay, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 14, 2018
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015)R Cantón, E Loza, J Aznar, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 15, 2019
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)R Cantón, E Loza, J Aznar, et al.
The Journal of Infection|February 29, 2012
Emerging trends in candidemia: a higher incidence but a similar outcomeJ Fortún, P Martín-Dávila, E Gómez-García de la Pedrosa, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 1, 2021
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018)R Cantón, E Loza, R M Arcay, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Annals of the Rheumatic Diseases|November 27, 2008
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeK Visser, W Katchamart, E Loza, et al.
Lupus|December 18, 2014
Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosusJ M Pego-Reigosa, Í Rúa-Figueroa, F J López-Longo, et al.
Pageof 10